Physiology and pathophysiology of bone remodeling

Clinical Chemistry

Volumn 45, Issue 8 II, 1999, Pages 1353-1358

  Raisz, Lawrence G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CALCITONIN; CALCITRIOL; ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE; PARATHYROID HORMONE; SOMATOMEDIN; THYROID HORMONE;

BONE DISEASE; BONE REMODELING; BONE TURNOVER; CELL DIFFERENTIATION; CONFERENCE PAPER; HETEROTOPIC OSSIFICATION; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PAGET BONE DISEASE; PATHOPHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE REMODELING; HUMANS; HYPERPARATHYROIDISM; HYPERTHYROIDISM; OSTEITIS DEFORMANS; OSTEOPETROSIS; OSTEOPOROSIS;

EID: 0032847386     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Turner CH. Three rules for bone adaptation to mechanical stimuli. Bone 1998;23:339-409.
2. Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocrinol Rev 1986;7:379-408.
3. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas STC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 1998;13:793-802.
4. Dempster DW, Cosman F, Parisien M, Shen V. Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993;14:690-709.
5. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R. et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998; 139:4391-6.
6. Rosen CJ, Donahue LR. Insulin-like growth factors and bone - the osteoporosis connection revisited. Proc Soc Exp Biol Med 1998; 219:1-7.
7. Advani S, LaFrancis D, Bogdanovic E, Taxel P, Raisz LG, Kream BE. Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal mice. Bone 1997;20:41-6.
8. Kawaguchi H, Pilbeam CC, Raisz LG. Anabolic effects of 3,3′,5-triiodothyronine and triiodothyroacetic acid in cultured neonatal mouse parietal bones. Endocrinology 1994;135:971-6.
9. Pacifici R. Cytokines, estrogen and postmenopausal osteoporosis - the second decade. Endocrinology 1998;139:2659-61.
10. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998;339:599-603.
11. Lorenzo JA. The role of cytokines in the regulation of local bone resorption. Crit Rev Immunol 1992;11:195-213.
12. McLeod KJ, Rubin CT, Otter MW, Qin YX. Skeletal cell stresses and bone adaptation. Am J Med Sci 1998;316:176-83.
13. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz, LG. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop 1995;313:36-46.
14. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998;139:4743-6.
15. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998;95:3597-602.
16. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor osteoprotegerin. Biochem Biophys Res Commun 1998; 247:610-5.
17. Hakeda Y, Kawaguchi H, Hurley M, Pilbeam CC, Abreu C, Linkhart TA, et al. Intact insulin-like growth factor binding protein-5 (IG-FBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse caivariae by parathyroid hormone and prostaglandin E2-treatment. J Cell Physiol 1996;166:370-9.
18. Bonewald LF, Dallas SL. Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 294;55: 350-7.
19. Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 1998;22:591-603.
20. Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 1997;97:561-70.
21. Inui K, Maeda H, Sario A, Fujioka K, Yutani Y, Sakawa A. Local application of basic fibroblast growth factor minipellet induces the healing of segmental bony defects in rabbits. Calcif Tissue Int 1998;63:490-5.
22. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
23. Mills BG, Frausto A. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone. Calcif Tissue Int 1997;61:16-21.
24. Raisz LG. The osteoporosis revolution. Ann Intern Med 1997;126: 458-62.
25. Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-73.
26. Prestwood KM, Pilbeam CC, Raisz LG. Treatment of osteoporosis. Annu Rev Med 1995;46:249-56.
27. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998;338:736-46.
28. Derosa G, Testa A, Giacomini D, Carrozza C, Astazit P, Caradonna P. Prospective study of bone loss in pre-and post-menopausal women on L-thyroxine therapy for non-toxic goiter. Clin Endocrinol 1997;47:529-35.
29. Siris ES. Paget's disease of bone. J Bone Miner Res 1998;13: 1061-5.
30. Mee AP, Dixon JA, Hoyland JA, Davies M, Selby PL, Mawer EB. Detection of canine distemper virus in 100% of Paget's disease samples by in situ reverse transcriptase-polymerase chain reaction. Bone 1998;23:171-5.
31. Nellissery MJ, Padalecki SS, Brkanac Z, Singer FR, Roodman GD, Unni KK, et al. Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am J Hum Genet 1998;63:817-24.
32. Kolbl O, Knelles D, Barthel T, Kraus U, Flentje M, Eulert J. Randomized trial comparing early postoperative irradiation vs the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement. Int J Radiat Oncol Biol Phys 1997;39:961-6.
33. Mohanty M. Cellular basis for failure of joint prosthesis. Biomed Mater Eng 1996;6:165-72.
34. Schneider GB, Key LL, Popoff SN. Osteopetrosis. Therapeutic strategies. Endocrinologist 1998;409-17.
35. Charles JM, Key LL. Developmental spectrum of children with congenital osteopetrosis. J Pediatr 1998;132:371-4.